Trace Level Impurities in Pharmaceuticals
Learn more about the risk assessment and analytical challenges of detection and quantification of trace level impurities in pharmaceuticals.
Mutagenic impurities
Stay ahead and improve your skills! Receive tailored information on new separation science methods and applications.
Register for free learning now >>
Tips and Tricks for Analysis of Nitrosamine Impurities in Pharmaceuticals
Analysis of nitrosamines in pharmaceuticals presents certain unique challenges - interferences, elevated baselines, inconsistencies in quantifications, decreased method performance.
Identifying nitrosamines in drug products – expert insights
Why are there nitrosamines in drug substances and drug products, and what are the current regulatory guidance’s to help identify these mutagenic impurities?
GC/MS strategies for mutagenic impurities analysis
Key information for individuals looking to improve knowledge and analytical skills in the trace analysis of nitrosamines in pharmaceutical products.
Stay ahead and improve your skills!
Be the first to know as our team will send straight to your inbox tailored information on new separation science methods and applications..